Hoth Therapeutics Inc

0.00 (-0.13%)
: $0.83 -0.02 (-2.23%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Hoth Therapeutics Inc Stock, NASDAQ:HOTH

1 Rockefeller Plaza, Suite 1039, New York, New York 10020
United States of America
Phone: +1.646.756.2997
Number of Employees: 3


Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.